A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Vericel Corp stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 17,510 shares of VCEL stock, worth $756,256. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,510
Previous 17,510 -0.0%
Holding current value
$756,256
Previous $910,000 11.76%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$29.0 - $38.37 $9,425 - $12,470
325 Added 1.89%
17,510 $657,000
Q4 2022

Feb 13, 2023

BUY
$17.65 - $27.37 $105,899 - $164,220
6,000 Added 53.64%
17,185 $452,000
Q3 2022

Nov 10, 2022

BUY
$22.62 - $32.54 $253,004 - $363,959
11,185 New
11,185 $259,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.04B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.